ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 43 filers reported holding ONCOCYTE CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $39,000 | -48.0% | 25,949 | -25.0% | 0.00% | – |
| Q4 2021 | $75,000 | -35.3% | 34,606 | +6.4% | 0.00% | – |
| Q3 2021 | $116,000 | -79.4% | 32,513 | -66.8% | 0.00% | -100.0% |
| Q2 2021 | $562,000 | +0.7% | 97,877 | -9.0% | 0.00% | 0.0% |
| Q1 2021 | $558,000 | +144.7% | 107,507 | +12.9% | 0.00% | – |
| Q4 2020 | $228,000 | +72.7% | 95,193 | 0.0% | 0.00% | – |
| Q3 2020 | $132,000 | +5.6% | 95,193 | +45.9% | 0.00% | – |
| Q2 2020 | $125,000 | +52.4% | 65,227 | +94.8% | 0.00% | – |
| Q1 2020 | $82,000 | +10.8% | 33,478 | +1.2% | 0.00% | – |
| Q4 2019 | $74,000 | +7.2% | 33,095 | 0.0% | 0.00% | – |
| Q3 2019 | $69,000 | -15.9% | 33,095 | 0.0% | 0.00% | – |
| Q2 2019 | $82,000 | +530.8% | 33,095 | +417.1% | 0.00% | – |
| Q1 2018 | $13,000 | -56.7% | 6,400 | 0.0% | 0.00% | – |
| Q4 2017 | $30,000 | -37.5% | 6,400 | 0.0% | 0.00% | – |
| Q3 2017 | $48,000 | +45.5% | 6,400 | 0.0% | 0.00% | – |
| Q2 2017 | $33,000 | +17.9% | 6,400 | +6.6% | 0.00% | – |
| Q1 2016 | $28,000 | – | 6,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 2,982,557 | $5,697,000 | 6.44% |
| BROADWOOD CAPITAL INC | 14,716,204 | $28,108,000 | 2.20% |
| PURA VIDA INVESTMENTS, LLC | 5,983,724 | $11,429,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 99,282 | $190,000 | 0.90% |
| P.A.W. CAPITAL CORP | 200,000 | $382,000 | 0.43% |
| Penbrook Management LLC | 215,625 | $412,000 | 0.40% |
| EAM Investors, LLC | 241,769 | $462,000 | 0.10% |
| Private Wealth Partners, LLC | 150,000 | $287,000 | 0.04% |
| Phoenix Holdings Ltd. | 292,275 | $597,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 145,650 | $470,000 | 0.02% |